Results 231 to 240 of about 280,561 (284)

Intravitreal Dexamethasone Implant for the Management of Choroidal Neovascular Membrane in Pregnancy. [PDF]

Cureus
Mehdi I.
europepmc   +1 more source

Use of a multifocal electroretinogram to evaluate the therapeutic effect of a single intravitreal dexamethasone implant, Ozurdex^®, for refractory diabetic macular oedema. [PDF]

Int J Retina Vitreous
Mohammed ARA, Othman MFS, Khairat YM, Abdelrahman AAM.   +3 more
europepmc   +1 more source

Cytomegalovirus Retinitis Associated With Intravitreal Dexamethasone Implant Injection. [PDF]

J Vitreoretin Dis
Shoji MK, Sengillo JD, Shetty A, Uhr J, Sridhar J.   +4 more
europepmc   +1 more source

Short-Term Safety and Efficacy of PreserFlo™ Microshunt in Patients with Refractory Intraocular Pressure Elevation After Dexamethasone Implant Intravitreal Injection. [PDF]

J Clin Med
Bourauel L, Petrak M, Holz FG, Mercieca K, Weber C.   +4 more
europepmc   +1 more source

Efficacy of dexamethasone implant in the management of chronic central serous chorioretinopathy without choroidal neovascularization. [PDF]

Indian J Ophthalmol
Behera UC, Brar AS, Kelgaonkar A, Sahoo J, Narayanan R, Sadda SR.   +5 more
europepmc   +1 more source

Foveal adhesion of a dexamethasone implant: Evaluation and follow-up via multimodal imaging.

Oman J Ophthalmol
Niedzwiecka E, Martín JCM, Sánchez JG, Torres VM, Verdú EM.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

UVEITIS TREATED WITH DEXAMETHASONE IMPLANT

Retina, 2021
Purpose: To evaluate the real-life efficacy and safety of the intravitreal dexamethasone implant in uveitis. Methods: This retrospective observational multicentric study included 152 eyes treated exclusively by 358 dexamethasone ...
Mathis, Thibaud, Cerquaglia, Alessio, Weber, Michel, Guillarme-Sallit, Rebecca, Malcles, Ariane, Voirin, Nicolas, Servant, Marion, Sudhalkar, Aditya, Bilgic, Alper, Denis, Philippe, Seve, Pascal, Bodaghi, Bahram, Kodjikian, Laurent   +12 more
openaire   +4 more sources

Reverse Engineering the Ozurdex Dexamethasone Intravitreal Implant

International Journal of Pharmaceutics, 2023
Ozurdex is a biodegradable implant formulated for sustained-release delivery of the corticosteroid dexamethasone to the posterior segment of the eye. The small, rod-shaped implant is administered directly to the vitreous using a dedicated applicator, and releases drug for up to 6 months after administration.
Xiaoming Xu, Nathaniel A Lynd, Mark A Costello   +2 more
exaly   +3 more sources

Dislocation of Dexamethasone Intravitreous Implant

Archives of Ophthalmology, 2012
tiviral drugs. Eur J Ophthalmol. 2001;11(2):200-202. 22. Yang CM, Wang WW, Lin CP. Progressive outer retinal necrosis syndrome as an early manifestation of human immunodeficiency virus infection. J Formos Med Assoc. 1999;98(2):141-144. 23. Perez-Blazquez E, Traspas R, Mendez Marin I, Montero M.
Voykov, Bogomil Nikolov, Bartz-Schmidt, Karl U.   +1 more
openaire   +3 more sources

Dexamethasone intravitreal implant in serpiginous choroiditis

British Journal of Ophthalmology, 2016
To assess the efficacy and safety of dexamethasone (DEX) intravitreal implant in patients with active serpiginous choroiditis (SC) already receiving maximal tolerated systemic immunosuppressive therapy.In this retrospective longitudinal study we evaluated patients receiving 0.7 mg DEX intravitreal implant for active SC despite maximal systemic ...
Miserocchi, Elisabetta, Berchicci, Luigi, Iuliano, Lorenzo, Modorati, Giulio, Bandello, Francesco   +4 more
openaire   +2 more sources